Anti-SLC46A3 monoclonal antibody

Pre-made anti-SLC46A3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC46A3/SLC46A3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1744-Ab-1/ GM-Tg-hg-IP1744-Ab-2Anti-Human SLC46A3 monoclonal antibodyHuman
GM-Tg-rg-IP1744-Ab-1/ GM-Tg-rg-IP1744-Ab-2Anti-Rat SLC46A3 monoclonal antibodyRat
GM-Tg-mg-IP1744-Ab-1/ GM-Tg-mg-IP1744-Ab-2Anti-Mouse SLC46A3 monoclonal antibodyMouse
GM-Tg-cynog-IP1744-Ab-1/ GM-Tg-cynog-IP1744-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC46A3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1744-Ab-1/ GM-Tg-felg-IP1744-Ab-2Anti-Feline SLC46A3 monoclonal antibodyFeline
GM-Tg-cang-IP1744-Ab-1/ GM-Tg-cang-IP1744-Ab-2Anti-Canine SLC46A3 monoclonal antibodyCanine
GM-Tg-bovg-IP1744-Ab-1/ GM-Tg-bovg-IP1744-Ab-2Anti-Bovine SLC46A3 monoclonal antibodyBovine
GM-Tg-equg-IP1744-Ab-1/ GM-Tg-equg-IP1744-Ab-2Anti-Equine SLC46A3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1744-Ab-1/ GM-Tg-hg-IP1744-Ab-2; GM-Tg-rg-IP1744-Ab-1/ GM-Tg-rg-IP1744-Ab-2;
GM-Tg-mg-IP1744-Ab-1/ GM-Tg-mg-IP1744-Ab-2; GM-Tg-cynog-IP1744-Ab-1/ GM-Tg-cynog-IP1744-Ab-2;
GM-Tg-felg-IP1744-Ab-1/ GM-Tg-felg-IP1744-Ab-2; GM-Tg-cang-IP1744-Ab-1/ GM-Tg-cang-IP1744-Ab-2;
GM-Tg-bovg-IP1744-Ab-1/ GM-Tg-bovg-IP1744-Ab-2; GM-Tg-equg-IP1744-Ab-1/ GM-Tg-equg-IP1744-Ab-2
Products NameAnti-SLC46A3 monoclonal antibody
Formatmab
Target NameSLC46A3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC46A3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1744-Ag-1Recombinant multi-species S46A3/ SLC46A3/ FKSG16 protein


    Target information

    Target IDGM-IP1744
    Target NameSLC46A3
    Gene ID283537,71706,288454,712056,477324,101088541,781117,100062949
    Gene Symbol and Synonyms1200006F02Rik,FKSG16,RGD1307594,SLC46A3
    Uniprot AccessionQ7Z3Q1,Q5BK75,A5D7V7
    Uniprot Entry NameS46A3_HUMAN,S46A3_RAT,S46A3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000139508
    Target ClassificationN/A

    The target: SLC46A3, gene name: SLC46A3, also named as FKSG16. The protein encoded by this gene is a member of a transmembrane protein family that transports small molecules across membranes. The encoded protein has been found in lysosomal membranes, where it can transport catabolites from the lysosomes to the cytoplasm. This protein has been shown to be an effective transporter of the cytotoxic drug maytansine, which is used in antibody-based targeting of cancer cells. [provided by RefSeq, Dec 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.